Ken is a world-renowned expert on AAV. Most, if not all, of current understanding of the AAV biology stems form his work from the very beginning. His work has been instrumental in the development of recombinant AAV vectors. Ken also has had a longstanding interest in medical education, and has served as a member of the Liaison Committee on Medical Education. He is a past member of the Composite Committee of the United States Medical Licensing Examination and is a past Chair of the Association of American Medical Colleges. Ken has served on many scientific advisory committees including the Genetic Biology Panel of the NSF, the Virology Study Section at the NIH, the Board of Scientific Counselors of the National Institute of Allergy and Infectious Diseases, the Virology-Microbiology panel of the American Cancer Society (Chair), the Recombinant DNA Advisory Committee (Chair) of the NIH, and the National Advisory Research Resources Council (NARRC) of the NIH. He has also served similar roles for the EPA, the U.S. Army (NRC) and the Aaron Diamond AIDS Research Center. Ken recently retired as Director of the Genetics Institute at the University of Florida. Previously he served as Dean of the College of Medicine and Vice President for Health Affairs.
Ken is a member of the National Academy of Sciences and the Institute of Medicine of the National Academy of Sciences. He chairs the American Society for Microbiology Committee on Biodefense and is a member of the Cellular, Tissue and Gene Therapies advisory committee of the FDA. He also serves on Board of Lacerta Therapeutics, a recently launched AAV gene therapy company.
Ken received his BA degree from Harvard University, Cambridge, MA, and his MD/PhD degrees from the Johns Hopkins University, Baltimore, MD.